Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando López-Ríos

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
JTO Clinical and Research Reports|February 25, 2025
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLCHelena Bote-de Cabo, Marco Siringo, Esther Conde, et al.
Cancers|November 25, 2020
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of BiomarkersXabier Mielgo-Rubio, Virginia Calvo, Javier Luna, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2014
Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancerM Teresa Agulló-Ortuño, C Vanesa Díaz-García, Alba Agudo-López, et al.
Plos One|September 3, 2010
The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lungEsther Conde, Bárbara Angulo, Pilar Redondo, et al.
Studies in Health Technology and Informatics|May 23, 2026
Modelling and Implementation of a Precision-Oncology Data-Integration Platform for Real-Word Molecular Tumor Borad Decision-MakingJulia Hernández-Pérez, Ángel Martínez-González, Sandra Cruz-Ballesteros, et al.
Molecular Cancer Therapeutics|October 15, 2008
Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancerDongweon Song, Raghothama Chaerkady, Aik Choon Tan, et al.
JCO Precision Oncology|March 2, 2023
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference CentersEdurne Arriola, Reyes Bernabé, Rosario García Campelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2017
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung CancerReinhard Büttner, John R Gosney, Birgit Guldhammer Skov, et al.
Oncotarget|November 17, 2016
Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximabRodrigo A Toledo, Antonio Cubillo, Estela Vega, et al.
The Journal of Molecular Diagnostics : JMD|March 15, 2012
Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysisJeroen R Dijkstra, Frank J M Opdam, Jerry Boonyaratanakornkit, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
JTO Clinical and Research Reports|February 25, 2025
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLCHelena Bote-de Cabo, Marco Siringo, Esther Conde, et al.
Cancers|November 25, 2020
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of BiomarkersXabier Mielgo-Rubio, Virginia Calvo, Javier Luna, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2014
Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancerM Teresa Agulló-Ortuño, C Vanesa Díaz-García, Alba Agudo-López, et al.
Plos One|September 3, 2010
The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lungEsther Conde, Bárbara Angulo, Pilar Redondo, et al.
Studies in Health Technology and Informatics|May 23, 2026
Modelling and Implementation of a Precision-Oncology Data-Integration Platform for Real-Word Molecular Tumor Borad Decision-MakingJulia Hernández-Pérez, Ángel Martínez-González, Sandra Cruz-Ballesteros, et al.
Molecular Cancer Therapeutics|October 15, 2008
Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancerDongweon Song, Raghothama Chaerkady, Aik Choon Tan, et al.
JCO Precision Oncology|March 2, 2023
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference CentersEdurne Arriola, Reyes Bernabé, Rosario García Campelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2017
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung CancerReinhard Büttner, John R Gosney, Birgit Guldhammer Skov, et al.
Oncotarget|November 17, 2016
Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximabRodrigo A Toledo, Antonio Cubillo, Estela Vega, et al.
The Journal of Molecular Diagnostics : JMD|March 15, 2012
Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysisJeroen R Dijkstra, Frank J M Opdam, Jerry Boonyaratanakornkit, et al.
Pageof 6